CA2454853A1 - Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier - Google Patents
Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier Download PDFInfo
- Publication number
- CA2454853A1 CA2454853A1 CA002454853A CA2454853A CA2454853A1 CA 2454853 A1 CA2454853 A1 CA 2454853A1 CA 002454853 A CA002454853 A CA 002454853A CA 2454853 A CA2454853 A CA 2454853A CA 2454853 A1 CA2454853 A1 CA 2454853A1
- Authority
- CA
- Canada
- Prior art keywords
- conjugate
- hapten
- carrier
- carbohydrate
- aldehyde
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
- A61K39/001172—Sialyl-Thomson-nouvelle antigen [sTn]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31185001P | 2001-08-14 | 2001-08-14 | |
| US60/311,850 | 2001-08-14 | ||
| PCT/US2002/024735 WO2003015796A1 (en) | 2001-08-14 | 2002-08-05 | Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2454853A1 true CA2454853A1 (en) | 2003-02-27 |
Family
ID=23208785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002454853A Abandoned CA2454853A1 (en) | 2001-08-14 | 2002-08-05 | Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040247608A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1429785A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005526692A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1543350A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2454853A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003015796A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080081045A1 (en) * | 2003-10-14 | 2008-04-03 | Biomira, Inc. | Combination Therapy for Cancer |
| CN102276662B (zh) * | 2010-06-09 | 2014-05-14 | 北京大学 | 唾液酸(α-(2→6))-D-吡喃糖衍生物及其合成方法和应用 |
| EP3046588B1 (en) | 2013-09-17 | 2022-03-02 | OBI Pharma, Inc. | Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment |
| MY188880A (en) * | 2014-09-15 | 2022-01-12 | Obi Pharma Inc | Immunogenic/therapeutic glycoconjugate compositions and uses thereof |
| EP3344806A4 (en) | 2015-09-04 | 2019-03-20 | OBI Pharma, Inc. | GLYCANARRAYS AND METHOD OF USE |
| AU2017239637A1 (en) | 2016-03-29 | 2018-11-15 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| US10980894B2 (en) | 2016-03-29 | 2021-04-20 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| IL262296B2 (en) | 2016-04-22 | 2024-09-01 | Obi Pharma Inc | Cancer immunotherapy by immune activation or immune modulation via globo series antigens |
| KR20190067765A (ko) | 2016-07-27 | 2019-06-17 | 오비아이 파머 인코퍼레이티드 | 면역원성/치료 글리칸 조성물 및 그의 용도 |
| KR102528998B1 (ko) | 2016-07-29 | 2023-05-03 | 오비아이 파머 인코퍼레이티드 | 인간 항체, 제약 조성물 및 방법 |
| CN106645697A (zh) * | 2016-11-09 | 2017-05-10 | 百奥森(江苏)食品安全科技有限公司 | 一种食品中玉米赤霉醇的检测试剂盒 |
| CN106526188A (zh) * | 2016-11-09 | 2017-03-22 | 百奥森(江苏)食品安全科技有限公司 | 一种食品中沙丁胺醇的检测试剂盒 |
| WO2018094414A1 (en) | 2016-11-21 | 2018-05-24 | Obi Pharma, Inc. | Conjugated biological molecules, pharmaceutical compositions and methods |
| TW202504930A (zh) | 2018-06-27 | 2025-02-01 | 台灣浩鼎生技股份有限公司 | 用於糖蛋白工程的糖苷合成酶變體及其使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5407912A (en) * | 1993-04-19 | 1995-04-18 | Akzo, N.V. | Method of treating bladder cancer with a keyhole limpet hemocyanin composition with enhanced anti-tumor activity |
| AU2247095A (en) * | 1994-04-12 | 1995-10-30 | Biomira Inc. | Cellular immune response-specific antigens and uses therefor |
| WO1995029927A2 (en) * | 1994-05-02 | 1995-11-09 | Biomira, Inc. | Process for preparation of glycosides of tumor-associated carbohydrate antigens |
| EP1091751A4 (en) * | 1998-03-25 | 2005-01-19 | Sloan Kettering Institutefor C | TRIMERIC OXYGENIC BINDING GLYCOPEPTIDE CONJUGATES, METHODS OF PREPARATION AND USE THEREOF |
-
2002
- 2002-08-05 US US10/486,646 patent/US20040247608A1/en not_active Abandoned
- 2002-08-05 EP EP02750420A patent/EP1429785A4/en not_active Withdrawn
- 2002-08-05 CA CA002454853A patent/CA2454853A1/en not_active Abandoned
- 2002-08-05 WO PCT/US2002/024735 patent/WO2003015796A1/en not_active Ceased
- 2002-08-05 JP JP2003520755A patent/JP2005526692A/ja not_active Abandoned
- 2002-08-05 CN CNA028160711A patent/CN1543350A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005526692A (ja) | 2005-09-08 |
| EP1429785A1 (en) | 2004-06-23 |
| WO2003015796A1 (en) | 2003-02-27 |
| EP1429785A4 (en) | 2005-12-14 |
| US20040247608A1 (en) | 2004-12-09 |
| CN1543350A (zh) | 2004-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20040247608A1 (en) | Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier | |
| Avci et al. | A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design | |
| JP6784646B2 (ja) | アルツハイマー型認知症の予防用及び免疫療法用ペプチドワクチン | |
| Yarovinsky et al. | Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response | |
| US11904002B2 (en) | Construction and methods of use of a therapeutic cancer vaccine library comprising fusion-specific vaccines | |
| EP1379552B1 (en) | Toll-like receptor 5 ligands and methods of use | |
| EP3046588B1 (en) | Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment | |
| CZ20022748A3 (cs) | Nová metoda regulace obsahu amyloidu | |
| KR102702705B1 (ko) | 면역원성/치료적 당접합체 조성물 및 그의 용도 | |
| SK287468B6 (sk) | Použitie analógu autológneho Aß alebo APP polypeptidu živočícha, analóg, fragment nukleovej kyseliny, vektor, transformovaná bunka, bunková línia a kompozície | |
| JP2004538332A (ja) | β−アミロイドアナログ−T細胞エピトープワクチン | |
| KR20230080397A (ko) | 알츠하이머 질환을 치료하기 위한 멀티에피토프 백신 | |
| JPH10510424A (ja) | レクザイム及び糖質リガンドの同定浄化及び使用 | |
| US11708411B2 (en) | Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines | |
| JPH07505365A (ja) | 耐性の誘導に有用なペプチド | |
| KR20230087487A (ko) | 시누클레인 병증을 치료하기 위한 α-시누클레인 백신 | |
| JP2023525276A (ja) | 延長された酸化還元酵素モチーフを有する免疫原性ペプチド | |
| WO1995027505A1 (en) | Cellular immune response-specific antigens and uses therefor | |
| US20260097104A1 (en) | Methods of Formulating a Vaccine | |
| AU2002319755A1 (en) | Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier | |
| US20240238414A1 (en) | Anti-parasitic immunological compositions | |
| US9358302B2 (en) | Glycoconjugate vaccines | |
| KR20130106786A (ko) | 골수유래억제세포 및 레바미피드를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
| US20250041278A1 (en) | Tlr8 agonist for modulating immune response | |
| US20250000971A1 (en) | Tlr4 agonist for modulating immune response |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |